Skip to main content
Terminated

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

By April 24, 2017No Comments

Condition

Cancer of the Head and Neck

Estimated Enrollment: 8

Age Group: 18 Years and older   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: UCI 04-08|2004-3776

Study First Received: November 17, 2005

Last Updated: December 2, 2016

Estimated Primary Completion Date: February 2008

 

Primary Outcome Measures:

Overall Response Rate (Complete and Partial Response)|Frequency and Severity of Toxicities|Overall Survival and Time to Treatment Failure

Sponsors and Collaborators:

Sai-Hong Ignatius Ou|Sanofi|University of California, Irvine

Website Link: https://ClinicalTrials.gov/show/NCT00256295

Leave a Reply